Google DeepMind and BioNTech are building AI lab assistants to help researchers plan scientific experiments and better ...

Company Conference Call October 1, 2024 9:00 AM ETCompany ParticipantsKarim Beguir - Chief Executive Officer, InstaDeepUğur ...

The BioNTech SE ADR BNTX advanced 2.40% to $122.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...

BioNTech has a broad and diversified cancer drug pipeline extending well beyond mRNA based approaches. Sam Fazeli, Senior Health Care Analyst, speaks to Ryan Richardson, Chief Strategy Officer, who ...

Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipeline Highlights InstaDeep’s new near exascale supercomputer, Kyber, with the aim of ...

LONDON - BioNTech SE (NASDAQ:BNTX), in collaboration with its AI subsidiary InstaDeep Ltd., has presented an update on its artificial intelligence (AI) strategies during its Innovation Series ...

Investors are pouring cash into artificial intelligence-related health care startups at twice the rate of the AI tech sector ...

Simply sign up to the Artificial intelligence myFT Digest -- delivered directly to your inbox. Google DeepMind and BioNTech are building AI lab assistants to help researchers plan scientific ...